PointState Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-18,973
Closed -$5.12M 101
2021
Q4
$5.12M Sell
18,973
-31,661
-63% -$7.84M 0.08% 86
2021
Q3
$12.2M Buy
50,634
+33,174
+190% +$8.36M 0.2% 71
2021
Q2
$4.14M Buy
+17,460
New +$3.98M 0.07% 100
2021
Q1
Sell
-28,920
Closed -$5.06M 147
2020
Q4
$5.06M Sell
28,920
-94,250
-77% -$16.3M 0.1% 93
2020
Q3
$19.9M Buy
+123,170
New +$19.5M 0.52% 44
2018
Q4
Sell
-239,636
Closed -$35.8M 116
2018
Q3
$35.8M Buy
+239,636
New +$36.5M 0.47% 43
2018
Q1
Sell
-145,616
Closed -$20M 187
2017
Q4
$20M Sell
145,616
-195,203
-57% -$25.8M 0.19% 81
2017
Q3
$44.2M Buy
+340,819
New +$45.5M 0.38% 59
2015
Q3
Sell
-968,332
Closed -$101M 120
2015
Q2
$101M Sell
968,332
-84,273
-8% -$8.77M 1.18% 25
2015
Q1
$114M Buy
1,052,605
+819,805
+352% +$84.3M 1.54% 17
2014
Q4
$21.6M Buy
+232,800
New +$20.6M 0.37% 60

Other funds holding LH

PointState Capital's LH Position: Q1 2022 in Review

PointState Capital sold out of Labcorp (LH) in Q1 2022, closing a stake of 18,973 shares — an estimated $5.12M sold.

PointState Capital first reported a position in LH in Q4 2014 and held it in 11 quarters. The position peaked at $114M in Q1 2015. 1,033 funds tracked by Wall St. Rank hold LH as of Q1 2022.

  • PointState Capital reported no remaining Labcorp position as of Q1 2022 after selling out during the quarter.
  • PointState Capital sold 18,973 Labcorp shares in Q1 2022, an estimated $5.12M.
  • PointState Capital first reported a position in Labcorp in Q4 2014 and held it in 11 quarters.
  • PointState Capital's Labcorp position peaked at $114M in Q1 2015.
  • 1,033 funds tracked by Wall St. Rank held Labcorp as of Q1 2022.

Based on PointState Capital's 13F filing for Q1 2022, filed 13 May 2022.